Is early treatment for gestational diabetes overrated? new study investigates
NCT ID NCT04451915
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at whether treating gestational diabetes early (before 24 weeks) is better than waiting until the standard 24-28 week screening. About 2,010 pregnant women with mild early high blood sugar will be randomly assigned to either start intensive treatment right away or wait for later screening. The goal is to see if waiting is just as safe for mothers and babies, which could simplify care and reduce unnecessary treatments.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could show that waiting to treat mild gestational diabetes is safe, potentially reducing unnecessary early treatments and stress for pregnant women.
- What could go wrong
- This is an early-stage study comparing two management strategies, not testing a new drug. The results may not apply to all women, and there is a chance that delaying treatment could increase risks for some.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GESTATIONAL DIABETES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CH ARRAS
RECRUITINGArras, France
-
Ch Rene Dubos - Pontoise
RECRUITINGPontoise, France
-
Chu Nimes Caremeau - Nimes 9
RECRUITINGNîmes, France
-
Chu Site Sud (Saint Pierre) - St Pierre
RECRUITINGSaint-Pierre, France
-
Csapa / Hus / Hopital Civil - Strasbourg
RECRUITINGStrasbourg, 67091, France
-
Hop Claude Huriez Chu Lille
RECRUITINGLille, 59037, France
-
Hopital Estaing - Chu63 - Clermont Ferrand
RECRUITINGClermont-Ferrand, France
-
Hopital Haut-Leveque - Chu - Pessac
RECRUITINGPessac, 33604, France
-
Hopital Saint Vincent - Saint Antoine - Lille
RECRUITINGLille, 59037, France
-
Hopital de Rangueil Chu Toulouse
RECRUITINGToulouse, 31300, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Wearable sensor may replace the dreaded glucose drink test for gestational diabetes
- Can a phone app tame gestational diabetes?
- Wearable tech could stop Post-Pregnancy diabetes in its tracks
- Could oxidative stress be the hidden culprit behind blood vessel damage after gestational diabetes?
- Blood vessel damage after gestational diabetes: is a rogue enzyme to blame?
- A simple nudge after childbirth could transform lifelong health for moms with chronic conditions